In 2024, UAB "Innovative Pharma Baltics" had revenue of 2.6 million EUR and profit of 80.9 thousand EUR.
year | Revenue | Profit | Assets | Liabilities | Equity | Employees |
|---|---|---|---|---|---|---|
| 2024 | 2 626 420 € +49.8% | 80 890 € -12.3% | - | 0 € | 1 075 924 € | - |
| 2023 | 1 752 950 € +0.2% | 92 285 € -64.8% | - | 0 € | 995 035 € | - |
| 2022 | 1 749 843 € +41.7% | 262 220 € +230.9% | - | 0 € | 923 715 € | - |
| 2021 | 1 235 061 € +1.1% | 79 242 € -5.6% | - | 0 € | 661 493 € | - |
Overall Rating | A87/100 |
Financial Health | 95/100 |
Credit History | 70/100 |
Legal History | 100/100 |
Business Activity | 85/100 |
| Overall Risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
UAB "Innovative Pharma Baltics" is located at Vilnius, Mokslininkų g. 6A, LT-08412.
In 2024, UAB "Innovative Pharma Baltics" had revenue of 2 626 420 EUR and profit of 80 890 EUR. Compared to previous year, revenue increased by 49.8%. View full financial report →
The shareholders of UAB "Innovative Pharma Baltics" include 4 Lithuanian natural persons and 1 Lithuanian legal entities. View ownership details →
Yes, UAB "Innovative Pharma Baltics" is registered as an active VAT payer with VAT number LT100004562118.
UAB "Innovative Pharma Baltics" was founded on April 8, 2008. The company has been operating for 18 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company Age | 18 years | 5 - 9 | 54% | |
Net Revenue | 2 626 420,00 € | 3 - 7 | 69% | |
Profit | 80 890,00 € | 1 - 5 | 85% | |
Equity | 1 075 924,00 € | 4 - 8 | 50% | |
Profitability | 3.1% | - | 10% |
Registered as a VAT payer.
Registered in the Lithuanian Register of Legal Entities.